Related Experiment Video
Updated: Jun 30, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Reprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposure
Hana Kolesova1,2, Petra Hrabalova3,4, Romana Bohuslavova3
1Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czechia.
Insights
Maternal diabetes and a deficient HIF-1α pathway impair offspring cardiac sympathetic development, leading to heart abnormalities and increased neonatal death risk. This highlights the critical role of the intrauterine environment in cardiovascular health.
Area of Science:
- Developmental Biology
- Cardiovascular Science
- Endocrinology
Background:
- Maternal diabetes is a risk factor for offspring complications, including cardiovascular issues.
- Abnormalities in the cardiac sympathetic system are linked to infant mortality and heart defects.
- Mechanisms linking maternal diabetes to cardiac sympathetic system development are poorly understood.
Purpose of the Study:
- To investigate the combined impact of maternal diabetes and a deficient Hypoxia-Inducible Factor 1-alpha (HIF-1α) pathway on cardiac sympathetic system development.
- To analyze heart development and cardiac sympathetic system formation in a mouse model under these conditions.
Main Methods:
- Utilized a mouse model combining maternal diabetes with a Hif1a-deficient sympathetic system.
- Conducted comprehensive analysis of heart and cardiac sympathetic system development.
- Employed RNA sequencing (RNA-seq) for transcriptional profiling of sympathetic neurons.
Main Results:
- Maternal diabetes and Hif1a deficiency synergistically impaired cardiac sympathetic innervation and adrenal medulla development.
- Observed smaller hearts, reduced ventricular wall thickness, dilated coronary vessels, and anomalous coronary artery branching.
- RNA-seq revealed significant changes in Hif1a-deficient sympathetic neurons related to cell cycle, proliferation, and mitosis.
Conclusions:
- Inadequate HIF-1α pathway activation, especially with maternal diabetes, contributes to cardiac sympathetic system abnormalities.
- The interplay between cardiac sympathetic deficiencies and vascular/myocardial alterations increases cardiovascular disease risk.
- These developmental issues diminish adaptability to extrauterine life, raising neonatal mortality risk.
Introduction:
Maternal diabetes is a recognized risk factor for both short-term and long-term complications in offspring. Beyond the direct teratogenicity of maternal diabetes, the intrauterine environment can influence the offspring's cardiovascular health. Abnormalities in the cardiac sympathetic system are implicated in conditions such as sudden infant death syndrome, cardiac arrhythmic death, heart failure, and certain congenital heart defects in children from diabetic pregnancies. However, the mechanisms by which maternal diabetes affects the development of the cardiac sympathetic system and, consequently, heightens health risks and predisposes to cardiovascular disease remain poorly understood.
Methods And Results:
In the mouse model, we performed a comprehensive analysis of the combined impact of a Hif1a-deficient sympathetic system and the maternal diabetes environment on both heart development and the formation of the cardiac sympathetic system. The synergic negative effect of exposure to maternal diabetes and Hif1a deficiency resulted in the most pronounced deficit in cardiac sympathetic innervation and the development of the adrenal medulla. Abnormalities in the cardiac sympathetic system were accompanied by a smaller heart, reduced ventricular wall thickness, and dilated subepicardial veins and coronary arteries in the myocardium, along with anomalies in the branching and connections of the main coronary arteries. Transcriptional profiling by RNA sequencing (RNA-seq) revealed significant transcriptome changes in Hif1a-deficient sympathetic neurons, primarily associated with cell cycle regulation, proliferation, and mitosis, explaining the shrinkage of the sympathetic neuron population.
Discussion:
Our data demonstrate that a failure to adequately activate the HIF-1α regulatory pathway, particularly in the context of maternal diabetes, may contribute to abnormalities in the cardiac sympathetic system. In conclusion, our findings indicate that the interplay between deficiencies in the cardiac sympathetic system and subtle structural alternations in the vasculature, microvasculature, and myocardium during heart development not only increases the risk of cardiovascular disease but also diminishes the adaptability to the stress associated with the transition to extrauterine life, thus increasing the risk of neonatal death.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Regulation of Angiogenesis and Blood Supply

